AUS
NZ
UK
CA
USA
IND
Healthcare
-Copy_08_16_2024_18_09_35_877328.jpg)
AstraZeneca's Imfinzi Receives New US Approval for Early-Stage Lung Cancer
August 16, 2024 12:00 AM BST| By Team Kalkine MediaAn prominent player of,Healthcare sector,,AstraZeneca PLC has announced that its immunotherapy drug Imfinzi (durvalumab) has been granted an additional approval by the US Food and Drug Administration (FDA). The new approval allows Imfinzi to be used...
IXICO Expects Positive Performance in FY24 with New Contract Wins Boosting Revenue Outlook
August 14, 2024 09:31 AM BST| By Team Kalkine MediaIXICO plc (LSE:IXI), a leading medical imaging and advanced analytics company focused on neuroscience, has issued a promising trading update for the fiscal year ending 30 September 2024 (FY24). The company, renowned for delivering cutting-edge insigh...
IQ-AI Moves Closer to FDA Review with Phase 1 Trial Wrap-Up
August 14, 2024 12:00 AM BST| By Team Kalkine MediaIQ-AI Ltd has announced that its Phase 1 clinical trial for IB003, a gallium maltolate treatment for children's brain cancer, is nearing completion. This marks a significant milestone for the,healthcare Sector,company, which focuses on advanced medic...
AstraZeneca Becomes First UK-Listed Firm to Hit £200 Billion
August 14, 2024 12:00 AM BST| By Team Kalkine MediaAstraZeneca PLC (,LSE:AZN,) has made history as the first company listed on the London Stock Exchange to reach a market valuation exceeding £200 billion. This milestone was achieved following a 1.2% increase in the company's share price on Tuesday, w...
Celadon Pharmaceuticals Shares Fall as Funding Delays Impact Financial Position
August 12, 2024 11:33 AM BST| By Team Kalkine MediaCeladon Pharmaceuticals PLC (LSE: CEL) announced on Monday that it is still awaiting essential cash inflows, though its operations remain aligned with internal expectations.,Market Reaction and Share Performance,The company's shares dropped by 47% to...
Bivictrix Therapeutics Plans AIM Delisting to Advance Pipeline as Private Entity
August 12, 2024 11:31 AM BST| By Team Kalkine MediaBivictrix Therapeutics PLC (LSE: BVX) announced on Monday its decision to delist from AIM in order to seek funding as a private company to advance its drug development pipeline.,Financial Performance and Delisting Rationale,The company, based in Ches...
New Research Partnership Aims to Advance Corneal Treatment
August 12, 2024 11:22 AM BST| By Team Kalkine MediaBSF Enterprise PLC (LSE: BSFA), a biotech company listed on the Main Market and owner of Kerato Ltd, has announced a research partnership with the University of Montreal in Canada. This agreement outlines the terms for a collaborative effort aimed at...
Genedrive Secures Initial Order for CYP2C19-ID Test Following NICE Endorsement
August 12, 2024 11:13 AM BST| By Team Kalkine MediaGenedrive plc (LSE:GDR), a leader in point-of-care pharmacogenetic testing, has announced the receipt of an initial order for its CYP2C19-ID Kit and associated instruments, valued at approximately £0.1 million. This order follows the recent endorseme...
Celadon Pharmaceuticals Highlights Recent Progress and Financial Position
August 12, 2024 11:12 AM BST| By Team Kalkine MediaCeladon Pharmaceuticals Plc (LSE: CEL), a UK-based pharmaceutical firm specializing in cannabis-based medicines, reports that its operations are proceeding according to management expectations. The company has been managing its financial position car...
Hikma Pharmaceuticals Surpasses Expectations with Earnings Report
August 12, 2024 12:00 AM BST| By Team Kalkine MediaHikma Pharmaceuticals PLC, a key player in the,healthcare sector,, recently released its half-yearly financial results, which exceeded market expectations. The company reported revenues of US$1.6 billion, surpassing forecasts, and achieved statutory...
Assessing Haleon plc's Dividend Prospects Amid Flat Earnings
August 12, 2024 12:00 AM BST| By Team Kalkine MediaHaleon plc, a notable player in the,healthcare sector,, is approaching its ex-dividend date in just three days, which may be of interest to shareholders and those monitoring dividend payments. The ex-dividend date, which falls on the 15th of August,...
Oncimmune Holdings PLC Secures $1.5 Million Contract
August 09, 2024 09:03 AM BST| By Team Kalkine MediaOncimmune Holdings PLC (LSE: ONC), a company specializing in autoantibody profiling, has secured a new contract with a leading global pharmaceutical firm. The agreement, valued at no less than $1.5 million, follows a successful pilot project conducte...
How Did MaxCyte Perform in Its Second-Quarter Results?
August 09, 2024 12:00 AM BST| By Team Kalkine MediaMaxCyte, Inc. an,Healthcare sector,firm has released its second-quarter results, showcasing stronger-than-expected performance. The company's revenue reached US$10 million, surpassing expectations by 31%. Although MaxCyte reported a statutory loss of...
Hikma Pharmaceuticals Reports Increased Profit and Dividend Amid Strategic Acquisitions
August 08, 2024 12:00 PM BST| By Team Kalkine MediaHikma Pharmaceuticals PLC (LSE: HIK) has reported financial results for the first half of 2024. The company’s pretax profit increased by 43%, reaching £288 million, compared to £202 million in the same period last year. Revenue grew by 10%, totaling...
Assura plc Expands into Private Healthcare with £500 Million Acquisition of UK Hospital Portfolio
August 08, 2024 10:59 AM BST| By Team Kalkine MediaAssura plc (LSE:AGR), a leading UK healthcare property investor and developer, has announced a major expansion into the private healthcare sector with the acquisition of a fully operational UK private hospital portfolio from Northwest Healthcare Prop...
Faron Pharma Shares Rise After New CMO Appointment
August 07, 2024 02:18 PM BST| By Team Kalkine MediaFaron Pharmaceuticals Limited, operating in the,healthcare sector,, announced the appointment of Dr. Petri Bono as its new Chief Medical Officer (CMO), effective 15 August.,Faron Pharmaceuticals Limited revealed that Dr. Bono, formerly the CMO at Ter...
Genedrive Shares Drop 10% Following CEO Departure
August 07, 2024 01:49 PM BST| By Team Kalkine MediaGenedrive PLC, operating in the,Healthcare sector,, saw its shares decline by 10% following the announcement that CEO James Cheek has left the company by mutual agreement. Genedrive, experienced a decrease of 0.3p to 2.8p in early trading.,Dr. Gino M...
Glencore's EBITDA Falls in H1 2024 Results, Driven by Normalized Energy Markets
August 07, 2024 10:42 AM BST| By Team Kalkine MediaGlencore PLC (LSE:GLEN) reported a mixed set of results for the first half of 2024, reflecting significant shifts in the energy markets. The company's adjusted EBITDA stood at $6.3 billion, down 33% from the same period last year. This decline was ma...
Haleon PLC Appoints New Non-Executive Directors
August 06, 2024 01:11 PM BST| By Team Kalkine MediaHaleon PLC (LSE: HLN), the consumer healthcare company headquartered in Weybridge, Surrey, has announced the appointment of Alan Stewart and Nancy Avila as non-executive directors, effective September 1. Stewart, previously the Chief Financial Office...
GSK Declares £0.15 Dividend, Increasing Returns for Stakeholders
August 06, 2024 12:55 PM BST| By Team Kalkine MediaA significant player of,Healthcare Sector,GlaxoSmithKline PLC,has declared a dividend payment of £0.15 per share, scheduled for October 10th. This dividend corresponds to a yield of 3.7%, offering a notable return to stakeholders.,Dividend Coverage a...
